review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1014521771 |
P356 | DOI | 10.1007/BF01806817 |
P698 | PubMed publication ID | 8883971 |
P2093 | author name string | M Noguchi | |
I Miyazaki | |||
N Katev | |||
P2860 | cites work | Risk of lymphoedema following the treatment of breast cancer | Q34188725 |
Further analysis of predictive value of Helix pomatia lectin binding to primary breast cancer for axillary and internal mammary lymph node metastases | Q35977097 | ||
Flow cytometric analysis of cell surface carbohydrates in metastatic human breast cancer | Q35983140 | ||
Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance | Q36028138 | ||
Survival and recurrences five years after selective treatment for breast carcinoma | Q36042673 | ||
Helix pomatia and Ulex europeus lectin binding in human breast carcinoma. | Q36446996 | ||
The axilla: not a no-go zone | Q36481740 | ||
Prognostic factors in breast-cancer and their controversies (review). | Q37878948 | ||
Surgical management of stage I and stage II breast cancer | Q37952746 | ||
Predictive value of lectin binding on breast-cancer recurrence and survival | Q38349289 | ||
Non-palpable lesions of the breast detected by mammography--review of 1182 consecutive histologically confirmed cases | Q38511583 | ||
Modern thoughts on lymph nodes in breast cancer | Q38637100 | ||
Factors affecting the incidence of lymph node metastases in small cancers of the breast | Q38819432 | ||
Axillary micro- and macrometastases in breast cancer: prognostic significance of tumor size | Q40355725 | ||
Improved Axillary Staging of Breast Cancer with Sentinel Lymphadenectomy | Q40484056 | ||
Axillary dissection: current practice and technique | Q40499790 | ||
How should the axilla be treated in breast cancer? Why I favour axillary node clearance in the management of breast cancer | Q40590169 | ||
Controversies in primary breast cancer management | Q40779390 | ||
The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction | Q41447288 | ||
Breast cancer: risk of axillary recurrence in node-negative patients following partial dissection of the axilla | Q41779521 | ||
Invasive carcinoma of the breast: prognostic significance of tumor size and involved axillary lymph nodes | Q43448419 | ||
Axillary lymph node dissection for T1a breast carcinoma. Is it indicated? | Q43773890 | ||
The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer | Q44101084 | ||
Clinical and biological prediction of axillary and internal mammary lymph node metastases in breast cancer | Q45189104 | ||
Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases | Q45212226 | ||
Prediction of lymph node involvement in breast cancer by detection of altered glycosylation in the primary tumour | Q45270233 | ||
Relationship of the size of the invasive component of the primary breast carcinoma to axillary lymph node metastasis | Q47363180 | ||
Simple mastectomy and axillary node sampling (pectoral node biopsy) in the management of primary breast cancer | Q50175617 | ||
Prognostic value of axillary lymphoscintigraphy in breast carcinoma patients. | Q52494641 | ||
Lack of efficacy of xeroradiography to preoperatively detect axillary lymph node metastases in breast cancer. | Q52710850 | ||
The appropriate breast cancer paradigm. | Q53704177 | ||
Axillary lymph node metastases in breast cancer: preoperative detection with US. | Q53731414 | ||
New Therapeutic Possibilities in Primary Invasive Breast Cancer | Q58005119 | ||
Carcinoma in situ of the breast | Q66847257 | ||
Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. The Breast Carcinoma Collaborative Group of the Institut Curie | Q67516242 | ||
C-erbB-2 oncoprotein expression versus internal mammary lymph node metastases as additional prognostic factors in patients with axillary lymph node-positive breast cancer | Q67516787 | ||
The Guy's trial of treatments of "early" breast cancer | Q67597463 | ||
Total axillary lymphadenectomy in the management of breast cancer | Q67771144 | ||
Axillary node dissection for early breast cancer: some is good, but all is better | Q68035279 | ||
Prognostic importance of occult axillary lymph node micrometastases from breast cancers. International (Ludwig) Breast Cancer Study Group | Q68090559 | ||
Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis | Q68194992 | ||
Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer | Q68256199 | ||
Evidence for a novel gene associated with low tumor metastatic potential | Q68277146 | ||
Ultrasonographic detection of metastatic axillary lymph nodes in breast cancer | Q68519748 | ||
Intraductal carcinoma of the breast. (1960-1969) | Q68634226 | ||
Factors influencing survival and prognosis in early breast carcinoma (T1N0M0-T1N1M0). Assessment of 644 patients with median follow-up of 18 years | Q68856475 | ||
Elevated ras oncogene expression correlates with lymph node metastases in breast cancer patients | Q68896052 | ||
Prognosis of breast cancer with axillary node metastases after surgical treatment only | Q69397240 | ||
The correlation between the spread of metastases by level in the axillary nodes and disease-free survival in breast cancer. A multifactorial analysis | Q69397249 | ||
Ultrasound detection of axillary lymph node metastases in breast cancer | Q69492567 | ||
Real-time ultrasound, axillary mammography, and clinical examination in the detection of axillary lymph node metastases in breast cancer patients | Q69503752 | ||
Clinical evaluation of axillar lymph nodes compared to surgical and pathological findings | Q69513451 | ||
The significance of regional lymph node dissection in the surgical management of breast cancer | Q69630913 | ||
Hooked-wire-directed breast biopsy and overpenetrated mammography | Q69716747 | ||
Conservative treatment of breast cancer: results of management of axillary lymph node area in 3353 patients | Q69864846 | ||
Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation | Q69884400 | ||
The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: a controlled randomized trial | Q69891876 | ||
MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations | Q69945050 | ||
Patients with early breast cancer benefit from effective axillary treatment | Q70069828 | ||
CT-pathologic correlation of axillary lymph nodes in breast carcinoma | Q70147057 | ||
Axillary lymph node dissection for intraductal breast carcinoma--is it indicated? | Q70169494 | ||
Surgical treatment of carcinoma of the breast: II. Prognostic factors influencing relapse rate | Q70186666 | ||
Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update | Q70280709 | ||
Manchester regional breast study--5 and 10 year results | Q70595671 | ||
Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis | Q70611381 | ||
Occult axillary lymph node metastases in invasive breast carcinoma: characteristics of the primary tumor and significance of the metastases | Q70628565 | ||
MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation | Q70664515 | ||
Axillary nodal status in women with screen-detected breast cancer | Q70710082 | ||
Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance | Q70720534 | ||
The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast | Q70810976 | ||
Observations on short-term and long-term surveys of breast cancer by the American College of Surgeons. I. Significance of the number of axillary nodes and II. Estrogen receptor assay in the U.S. in 1977 | Q70828533 | ||
Nuclear magnetic resonance for the differentiation of benign and malignant breast tissues and axillary lymph nodes | Q71059693 | ||
Analysis of the prognosis of minimal and occult breast cancers | Q71137185 | ||
Assessment of axillary lymph node status | Q71288585 | ||
Reliability of axillary lymph node scintiphotography in suspected carcinoma of the breast | Q71353210 | ||
Intraoperative assessment of axillary lymph node metastases in operable breast cancer | Q71702885 | ||
Significance of Axillary Macrometastases and Micrometastases in Mammary Cancer | Q71757405 | ||
Lymphatic mapping and sentinel lymphadenectomy for breast cancer | Q72206697 | ||
Predicting axillary node positivity in patients with invasive carcinoma of the breast by using a combination of T category and palpability | Q72293954 | ||
Integrin expression in primary breast cancer and its relation to axillary nodal status | Q72380672 | ||
Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance | Q72424685 | ||
Cancer research campaign (King's/Cambridge) trial for early breast cancer. A detailed update at the tenth year. Cancer Research Campaign Working Party | Q72428294 | ||
Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction | Q72428499 | ||
The inadequacy of axillary sampling in breast cancer | Q72526584 | ||
The relationship of p53 protein and lymph node metastases in invasive breast cancer | Q72700246 | ||
Predictors of axillary lymph node metastases in patients with T1 breast cancer. A multivariate analysis | Q72736720 | ||
Management of the axilla in patients with breast cancers one centimeter or smaller | Q72848528 | ||
Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures | Q72939412 | ||
Controversies in the Surgical Management of Operable Breast Cancer | Q73223977 | ||
Significance of occult metastases.A study of breast cancer | Q79053159 | ||
Nm23 expression versus helix-pomatia lectin-binding in human breast-cancer metastases | Q84089658 | ||
Immunohistochemical study of epidermal growth-factor and epidermal growth-factor receptor in breast-carcinoma | Q84182421 | ||
Axillary nodes in breast cancer | Q93716211 | ||
Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance | Q93864552 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 11 | |
P304 | page(s) | 283-293 | |
P577 | publication date | 1996-01-01 | |
P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
P1476 | title | Diagnosis of axillary lymph node metastases in patients with breast cancer | |
P478 | volume | 40 |
Q73192060 | A multicenter validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society |
Q37900684 | Axillary recurrence rate in breast cancer patients with negative sentinel lymph node biopsy or containing micrometastases and without further lymphadenectomy: a monocentric review of 8 years and 481 cases |
Q34077063 | Axillary staging of breast cancer and the sentinel node |
Q77741852 | Breast cancer imaging--what are the optimal modalities? |
Q37542255 | Molecular markers of breast axillary lymph node metastasis |
Q48666718 | New method of sentinel node detection using a combination of contrast-enhanced ultrasound and dye guidance: an animal study. |
Q79978575 | Relationship between viral factors, axillary lymph node status and survival in breast cancer |
Q34536005 | Sentinel lymph node biopsy and breast cancer |
Q33634761 | Sentinel lymphadenectomy in breast cancer: identification of sentinel lymph node and detection of metastases |
Q73272419 | Staging efficacy of breast cancer with sentinel lymphadenectomy |
Q44661227 | The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer. |
Q38051233 | The changing role of axillary lymph node dissection for breast cancer |
Search more.